We have also summarized the studies on NaV1.7 binding sites, the use of NaV1.7 inhibitors in cancers and provided an overview of the possible mechanisms of action for NaV1.7 mediated cancer cell proliferation, migration and invasion. Here, SCN9A is linked to cancer.